China-Origin Drugmaker BeiGene to Rename Itself Amid Global Push

China’s leading innovative cancer drugmaker BeiGene Ltd. plans to change its name to BeOne Medicines as part of a rebranding to support its growth ambitions in markets including the US and Europe.Read More